documents: FDA-2024-E-0299-0005
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-E-0299-0005 | FDA | FDA-2024-E-0299 | Letter from FDA CDER to U.S. Patent and Trademark Office | Other | Letter(s) | 2024-02-09T05:00:00Z | 2024 | 2 | 2024-02-09T05:00:00Z | 2024-02-09T20:04:25Z | 0 | 0 | 09000064863f9e89 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref